tiprankstipranks
Aclaris Therapeutics (GB:0H8T)
LSE:0H8T
UK Market

Aclaris Therapeutics (0H8T) Income Statement

Compare
0 Followers

Aclaris Therapeutics Income Statement

Last quarter (Q4 2024), Aclaris Therapeutics's total revenue was $9.21M, a decrease of -47.58% from the same quarter last year. In Q4, Aclaris Therapeutics's net income was $-96.55M. See Aclaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 18.72M$ 31.25M$ 29.75M$ 6.76M$ 6.48M
Gross Profit
$ 15.93M$ 13.17M$ 17.79M$ 2.05M$ 1.35M
Operating Expenses
$ 157.86M$ 110.53M$ 102.95M$ 67.43M$ 52.26M
Depreciation and Amortization
$ 807.00K$ 863.00K$ 797.00K$ 923.00K$ 1.32M
EBITDA
$ -51.72M$ -117.56M$ -84.36M$ -65.06M$ -48.20M
Operating Income
$ -141.93M$ -97.36M$ -85.15M$ -65.38M$ -50.91M
Other Income/Expenses
$ 9.87M$ 8.51M$ 2.95M$ -1.14M$ -424.00K
Pretax Income
$ -132.06M$ -88.85M$ -86.91M$ -90.86M$ -51.34M
Net Income
$ -132.06M$ -88.48M$ -88.66M$ -114.28M$ -51.15M
Per Share Metrics
Basic EPS
$ -1.71$ -1.27$ -1.36$ -2.01$ -1.20
Diluted EPS
$ -1.71$ -1.27$ -1.36$ -2.01$ -1.20
Weighted Average Shares Outstanding
77.30M 69.81M 65.21M 56.73M 42.54M
Weighted Average Shares Outstanding (Diluted)
77.30M 69.81M 65.21M 56.73M 42.54M
Currency in USD

Aclaris Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis